Bo Pan Zhixin Hao Ying Xu Zhe Wang Ru Yao Xuefei Wang Chao Ren Yidong Zhou Qiang Sun Li Huo
10.3389/fonc.2022.1095779
Front Oncol
2022 Dec 23;12:1095779.
cdk4/6 inhibitor fes pet/ct estrogen receptor (er) metastatic breast cancer treatment response
CC BY
https://pubmed.ncbi.nlm.nih.gov/36620595/
Case Reports
PMC9816999
36620595
Case report: 18F-FES PET/CT predicted treatment responses of second-line and third-line CDK4/6 inhibitors after disease progression on first-line CDK4/6 inhibitor in a HR+/HER2- metastatic breast cancer patient
2022